S. Ray

发表

Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: Work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study

M. Weisman, R. V. van Vollenhoven, M. Cifaldi, 2010, Arthritis care & research.

Quality of life with Brain Symptom and Impact Questionnaire in patients with brain metastases.

Liying Zhang, D. Cella, A. Sahgal, 2016, Annals of palliative medicine.

Treatment Patterns and Outcomes in Patients With Hepatocellular Carcinoma Stratified by Stage-Guided Treatment Categories.

D. Brixner, D. Stenehjem, S. Ray, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Economic burden of dermatologic adverse drug reactions in the treatment of colorectal, non-small cell lung, and head and neck cancers with epidermal growth factor receptor inhibitors

E. Wu, A. Guérin, K. Holen, 2013, Journal of Medical Economics.

Direct medical costs associated with different lines of therapy for colorectal cancer patients

M. Bonafede, S. Ray, Jeffrey D. Miller, 2013 .

PCN39 Direct Medical Costs Associated With Different Lines of Therapy for Colorectal Cancer (CRC) Patients

M. Bonafede, S. Ray, S. Curkendall, 2012 .

Patterns of treatment, healthcare utilization and costs by lines of therapy in metastatic breast cancer in a large insured US population.

M. Bonafede, S. Ray, P. Landsman-Blumberg, 2013, Journal of comparative effectiveness research.

Patient Reported Outcomes Comparison of FACT-and EQ-5 D – Based Utility Scores in Cancer

D. Cella, A. Pickard, S. Ray, 2012 .

Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.

G. Colice, E. Wu, S. Ray, 2009, Clinical therapeutics.

Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population.

E. Hazard, D. Ollendorf, S. Ray, 2009, Clinical therapeutics.

Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the UK, Germany, France, Spain and Italy (EU-5): results from a physician survey.

Won Chan Lee, S. Ray, M. DeKoven, 2012, Journal of comparative effectiveness research.

Validation of the Brain Symptom and Impact Questionnaire (BASIQ) to assess symptom and quality of life in brain metastases.

Liying Zhang, D. Cella, A. Sahgal, 2014, CNS oncology.

PCN97 Preference Scores for 6 Types of Cancer Using Fact and EQ-5D

S. Ray, S. Pickard, A. Ganguli, 2012 .

Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population.

N. Mohile, M. Bonafede, S. Ray, 2014, American health & drug benefits.

Comparison of FACT- and EQ-5D-based utility scores in cancer.

D. Cella, A. Pickard, S. Ray, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Comparative analysis of survival, treatment, cost and resource use among patients newly diagnosed with brain metastasis by initial primary cancer

S. Ray, A. Teitelbaum, V. Bonthapally, 2013, Journal of Neuro-Oncology.

Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder

S. Frangou, S. Dursun, R. Devellis, 2005, Psychiatry Research.

Comparative analysis of individuals with and without chiropractic coverage: patient characteristics, utilization, and costs.

N. Dinubile, R. Metz, A. Legorreta, 2004, Archives of internal medicine.

Treatment patterns and healthcare costs among patients with advanced non-small-cell lung cancer

H. Henk, S. Ray, 2013 .

Medical care costs and survival associated with hepatocellular carcinoma among the elderly.

J. Menzin, M. Friedman, K. Lang, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The Brain Symptom and Impact Questionnaire in brain metastases patients: a prospective long-term follow-up study.

Liying Zhang, D. Cella, A. Sahgal, 2016, CNS oncology.

The impact of second-line agents on patients’ health-related quality of life in the treatment for non-small cell lung cancer: a systematic review

M. Botteman, J. Carter, S. Ray, 2013, Quality of Life Research.

Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population.

N. Mohile, M. Bonafede, S. Ray, 2014, American health & drug benefits.

Patterns of treatment, healthcare utilization and costs by lines of therapy in metastatic breast cancer in a large insured US population.

M. Bonafede, S. Ray, P. Landsman-Blumberg, 2013, Journal of comparative effectiveness research.

Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: Work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study

M. Weisman, R. V. van Vollenhoven, M. Cifaldi, 2010, Arthritis care & research.

CN2 Development of a Patient-Reported Outcome Instrument in Brain Metastases: The Brain Metastases Symptom and Impact Questionniare (BASIQ)

K. Lasch, F. Pompilus, S. Ray, 2012 .